Yanzheng Liu
Senior Director,
Aspen Neuroscience
Yanzheng Liu is a seasoned Senior Director in Cell and Gene Therapy Analytical Development and Quality Control (ADQC), bringing over 20 years of expertise in biopharmaceuticals. Currently, she leads quality control efforts for Aspen Neuroscience, Inc., when she oversees critical quality control operations for iPSC-based therapies. Prior to joining Aspen, she established and led ADQC functions at Sorrento Therapeutics for oncolytic immunotherapy manufacturing. Prior to Sorrento she held various positions of increasing responsibility at MilliporeSigma. Yanzheng Liu has a Ph.D. in microbiology and immunology.
Sessions